Regeneron Pharmaceuticals, Inc. (REGN)
754.08
-4.83
(-0.64%)
USD |
NASDAQ |
Jan 14, 16:00
751.37
-2.71
(-0.36%)
After-Hours: 20:00
Regeneron Pharmaceuticals EPS Diluted (Quarterly): 13.62 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Merck & Co., Inc. | 2.316 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.46B |
| Revenue (Quarterly) | 3.754B |
| Total Expenses (Quarterly) | 2.294B |
| Enterprise Value | 74.02B |
| Gross Profit Margin (Quarterly) | 82.47% |
| Profit Margin (Quarterly) | 38.89% |
| Earnings Yield | 5.54% |
| Operating Earnings Yield | 4.61% |
| Normalized Earnings Yield | 5.321 |